Search - tctmd.com

Displaying 41 - 60 of 264

Sort: Relevancy | Date

News Daily News

New Data Support Tighter Air Pollution Standards to Reduce CV Events

L.A. McKeown

February 27, 2023

News Daily News

Risk of Sports-Related Sudden Cardiac Arrest Low in Older Adults

Michael O'Riordan

February 09, 2023

News Daily News

Celiac Disease and CVD Link Bolstered in UK Biobank

Todd Neale

February 03, 2023

News Daily News

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

L.A. McKeown

February 02, 2023

News Daily News

Hypertension and Heavy Coffee Consumption a Bad Combo, Study Finds

L.A. McKeown

December 29, 2022

News Daily News

Improving AED Use for OHCAs With an App? Neutral Study Shows It’s Complicated

Yael L. Maxwell

December 05, 2022

News Daily News

Too Few Veterans Get Intensified Lipid-Lowering Therapy After Coronary Events

Yael L. Maxwell

October 24, 2022

Presentation TCT 2022

The Impact of Unloading: What We May Learn from the STEMI DTU RCT

Presenter: Navin Kapur

September 18, 2022

Presentation TCT 2022

Contemporary Techniques for Optimal Outcomes in High-Risk PCI

Presenter: Kate Kearney

September 18, 2022

Presentation TCT 2022

Percutaneous MCS Support for PCI in Surgically Ineligible Patients: Preliminary Results from Optimum

Presenter: Adam Salisbury

September 18, 2022

Presentation TCT 2022

Influential Trials in High-Risk PCI: Shaping the Future of Ischemic Heart Failure Therapy

Presenter: Jonathan Hill

September 18, 2022

Presentation TCT 2022

The Future of Sirolimus Coated Balloons: a look at the design of IDE clinical trials

Presenter: Azeem Latib

September 18, 2022

Presentation TCT 2022

Sirolimus Coated Balloon in real life complex settings: Case Presentations with long term FU and positive remodelling

Presenter: Sandeep Basavarajaiah

September 18, 2022

Presentation TCT 2022

Sirolimus-coated balloon: from EASTBOURNE, the Largest DCB study ever, to the next step, TRANSFORM 2 RCT

Presenter: Bernardo Cortese

September 18, 2022

Presentation TCT 2022

DCB in CAD: understanding the existing and new indications

Presenter: Antonio Colombo

September 18, 2022

Presentation TCT 2022

Sirolimus Coated Balloon with Nanolute Technology: Pre-clinical Insights and Rationale

Presenter: Aloke Finn

September 18, 2022

Presentation TCT 2022

Introduction & Session Objectives

Presenter: Martin Leon

September 18, 2022

Presentation TCT 2022

TARGET First: Short DAPT with Complete Revascularization Strategy

Presenter: Giuseppe Tarantini

September 18, 2022

Presentation TCT 2022

TARGET All Comers Trial 5-year Outcomes and Substudy Analysis

Presenter: Alexandra Lansky

September 18, 2022

Presentation TCT 2022

Conclusion

Presenter: Roxana Mehran

September 17, 2022

Advertisement

New Data Support Tighter Air Pollution Standards to Reduce CV Events

Risk of Sports-Related Sudden Cardiac Arrest Low in Older Adults

Celiac Disease and CVD Link Bolstered in UK Biobank

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

Hypertension and Heavy Coffee Consumption a Bad Combo, Study Finds

Improving AED Use for OHCAs With an App? Neutral Study Shows It’s Complicated

Too Few Veterans Get Intensified Lipid-Lowering Therapy After Coronary Events

The Impact of Unloading: What We May Learn from the STEMI DTU RCT

Contemporary Techniques for Optimal Outcomes in High-Risk PCI

Percutaneous MCS Support for PCI in Surgically Ineligible Patients: Preliminary Results from Optimum

Influential Trials in High-Risk PCI: Shaping the Future of Ischemic Heart Failure Therapy

The Future of Sirolimus Coated Balloons: a look at the design of IDE clinical trials

Sirolimus Coated Balloon in real life complex settings: Case Presentations with long term FU and positive remodelling

Sirolimus-coated balloon: from EASTBOURNE, the Largest DCB study ever, to the next step, TRANSFORM 2 RCT

DCB in CAD: understanding the existing and new indications

Sirolimus Coated Balloon with Nanolute Technology: Pre-clinical Insights and Rationale

Introduction & Session Objectives

TARGET First: Short DAPT with Complete Revascularization Strategy

TARGET All Comers Trial 5-year Outcomes and Substudy Analysis

Conclusion

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content